5. Patents

9 Months Ended

Jun. 30, 2014

Patents

Patents

On August 2, 2011, the Company was awarded U.S. Patent No. US 7,989,205 B2, titled Cell Culture Media, Kits, and Methods of Use. The Patent is for cell culture media kits for the support of primary culture of normal non-hematopoietic cells of mesodermal origin suitable for both research and clinical applications. The Company filed and maintains a continuation (U.S. Serial No. 13/194,900) with additional claims pending.

The Company has filed the following additional patents to extend its intellectual property to encompass additional aspects of the Company’s platform processing technologies:

● A Business Method for Collection Cryogenic Storage and Distribution of a Biologic Sample Material PCT/US2011/39260

● Systems and Methods for the Digestion of Adipose Tissue Samples Obtained from a Client for Cryopreservation U.S. Serial No. 13/646,647 filed October 5, 2012

● Compositions and Methods for Collecting, Washing, Cryopreserving, Recovering and Return of Lipaspirates to Physician for Autologous Adipose Transfer Procedures PCT/US13/44621 filed June 6, 2013

● Stem Cell-Based Therapeutic Devices and Methods U.S. Serial No. 14/196,414 Filed March 10, 2013

● Autologous Serum for Transport of Isolated Stromal Vascular Fraction or Adipose Derived Stem Cells 61/810,970 Filed April 11, 2013

● Cell Culture Media, Kits and Methods of Use US Serial No. 13/194,900 Continuation of US Serial No. 11/542,863

● Nanoparticle Mediated Synthetic Transcription Factor for Enhanced Gene Expression and Cell Differentiation 61/947,898 Filed March 28, 2014 (Jointly Owned with Rutgers University)